Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05427162 · ClinicalTrials.gov registry record · Phase 1
A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist
A Phase 1 study, sponsored by Actelion.
- Completed
- Registry status
- Phase 1
- Development phase
- 88
- Enrollment target
NCT05427162: Completed Phase 1 study, sponsored by Actelion.
NCT05427162 is a Phase 1 study that has completed, run by Actelion. The registered enrollment target is 88 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05427162, a Phase 1 study, has completed, sponsored by Actelion.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 88 participants
- Enrollment target
Study Summary
The purpose of the study is to assess safety and tolerability of prostacyclin receptor agonist formulation in treatment period 1 and with different formulation of prostacyclin receptor agonist in treatment period 2.
Primary Outcome
An adverse event is any untoward medical event that occurs in a participant administered an investigational product, and it does not necessarily indicate only events with clear causal relationship with the relevant investigational product. TEAEs are defined as AEs with onset or worsening on or after date of first dose of study treatment.
Interventions
- DRUG Prostacyclin Receptor Agonist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2022-06-21 |
| Est. Completion | 2023-12-05 |
| Phase | Phase 1 |
What the finished NCT05427162 record still lists
NCT05427162 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% higher).
The record links to 0 conditions, and to 1 intervention - of which Prostacyclin Receptor Agonist is the first listed.
NCT05427162 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05427162 about?
NCT05427162 is a clinical study titled "A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist". The purpose of the study is to assess safety and tolerability of prostacyclin receptor agonist formulation in treatment period 1 and with different formulation of prostacyclin receptor agonist in treatment period 2.
What is the current status of trial NCT05427162?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2022-06-21. Estimated completion is 2023-12-05.
What interventions are being tested in trial NCT05427162?
The interventions under investigation include: Prostacyclin Receptor Agonist (DRUG).
Who is sponsoring clinical trial NCT05427162?
This trial is sponsored by Actelion, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05427162's enrollment target sits among peer trials
88 650th of 2000 higher than 1,350 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI